Share This Activity
From:
To:
Subject: I'd like to recommend this activity on www.PracticePointCME.com
Message:

HIV

The Long Reach of Potent ART<font color="red"> - Updated 3/7/17
Certified CME/CNE/CPE Activity - Mini Modules

HIV-associated immune deficiency, the direct effects of HIV on end organs, and the indirect effects of HIV-associated inflammation on these organs all likely contribute to HIV-related morbidity and mortality. Untreated HIV infection and ongoing viral replication may have negative effects at all stages of infection and earlier treatment may prevent the damage associated with HIV replication during early stages of infection. ART confers benefits even when initiated later in infection; however, later therapy may not repair damage associated with viral replication during early stages of infection.

These educational mini modules explain how sustaining viral suppression and maintaining higher CD4 count levels, mostly as a result of combination ART, may delay, prevent, or reverse some non-AIDS-defining complications, such as HIV-associated kidney disease, liver disease, cardiovascular disease, neurologic complications, and malignancies.

Updated information is noted on the slide in the upper right hand corner. Please note that participants who have previously claimed credit for this activity should not claim duplicate credit based on the updates.

Review one (or all) Mini Modules of interest. Claim AMA, ANCC, or ACPE credit/contact hour(s) per module after completion of each brief Post-Test/Evaluation.
Sharon Walmsley, MD, FRCPC
Sharon Walmsley, MD, FRCPC
Director, HIV Clinical Research
Immunodeficiency Clinic
University Health Network
Toronto General Hospital
Professor of Medicine
University of Toronto
Toronto, Ontario, Canada




Please review the below required information (use scroll bar on the right)
and then click the
"Download Slides"
button to access this activity

INTRODUCTION

These educational Mini Modules will explain how sustaining viral suppression and maintaining higher CD4 count levels, mostly as a result of combination ART, may delay, prevent, or reverse some non-AIDS-defining complications.

Release Date: December 1, 2016
Expiration Date: November 30, 2017

TARGET AUDIENCE

This activity is intended for physicians, physician assistants, nurse practitioners, nurses, and pharmacists who treat/manage patients with HIV/AIDS.

LEARNING OBJECTIVES

Upon completion of this enduring material, participants should be able to:

    METHOD OF PARTICIPATION / HOW TO RECEIVE CREDIT

    • There are no fees for participating in and receiving credit for this activity.
    • Review the activity objectives and CME/CE information.
    • Review all modules associated with this course
    • Successfully complete the post-test (80% accuracy)
    • Complete the CME/CE evaluation
    • The estimated time to complete this activity is hour.
    • Upon successful completion of the initial evaluation, your CME/CNE certificate will be available to print for your records. CPE credit will be submitted to the University of Florida and posted to CPE Monitor

    JOINT PROVIDERSHIP

    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Nebraska Medical Center, Center for Continuing Education, the University of Nebraska Medical Center College of Nursing Continuing Nursing Education, the University of Florida College of Pharmacy, and Practice Point Communications.

    ACCREDITATION STATEMENTS

    University of Nebraska

    PHYSICIANS
    The University of Nebraska Medical Center, Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

    The University of Nebraska Medical Center, Center for Continuing Education designates this enduring material for a maximum of AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    NURSES
    The University of Nebraska Medical Center College of Nursing Continuing Nursing Education is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

    This activity is provided for contact hours under ANCC criteria.

    ACPE

    Pharmacists
    The University of Florida College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education (UAN # ).

    This activity is accredited for hour of continuing pharmacy education (CPE) credit. The University of Florida College of Pharmacy will report all credit to CPE Monitor within 30 working days after receiving evidence of successful completion of the course. Successful completion includes achieving a score of at least 80% on the test and completed evaluation.

    Participation in the entire knowledge based activity is required to obtain a certificate. This activity is being presented without bias and with commercial support.

    RESOLUTION OF CONFLICT OF INTEREST

    In accordance with the ACCME Standards for Commercial Support of CME, the University of Nebraska Medical Center, Center for Continuing Education, College of Nursing Continuing Nursing Education, the University of Florida College of Pharmacy, and Practice Point Communications will implement mechanisms, prior to the planning and implementation of this CME/CE activity, to identify and resolve conflicts of interest for all individuals in a position to control content of this CME/CE activity.

    DISCLOSURE

    All planners and faculty participating in continuing education activities provided by the University of Nebraska Medical Center, Center for Continuing Education, University of Nebraska Medical Center, College of Nursing Continuing Nursing Education, and the University of Florida College of Pharmacy are expected to disclose to the audience any support or relationship(s) with providers of commercial products and/or devices discussed in this activity and/or with any commercial supporters of the activity. A commercial interest is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. Disclosure of these commitments and/or relationships is included in activity materials so that participants in the activity may formulate their own judgments in interpreting its content and evaluating its recommendations. In addition, all faculty are expected to openly disclose any off-label, experimental, or investigational use of drugs or devices discussed in their presentation. The planners and faculty have been advised that this activity must be free from commercial bias, and based upon all the available scientifically rigorous data from research that conforms to accepted standards of experimental design, data collection, and analysis.

    All materials are included with the permission of the authors. The opinions expressed are those of the authors and are not to be construed as those of the University of Nebraska Medical Center, Center for Continuing Education or the University of Nebraska Medical Center, College of Nursing Continuing Nursing Education, and the University of Florida College of Pharmacy.

    The following indicates the disclosure declaration information and the nature of those commercial relationships.

    DISCLOSURES

    The speakers and planning committee members listed below have stated they have no significant relationships to disclose.
    Heidi Keeler, PhD, RN
    Uriel Sandkovsky, MD
    Lois Colburn
    Kristin Weitzel, Pharm.D., FAPhA
    Chris Fleming
    Kelly McCulloch

    The following speakers and/or planners have stated that they have the following financial relationship(s) and they have agreed to see that all information they planned and/or present is done so fairly and without bias:

    FACULTY DISCLOSURES

    Sharon Walmsley, MD
    Grant/research support: Abbvie, Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline, Merck Canada, ViiV
    Consultant: None
    Speaker's bureau: Abbvie, Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline, Merck Canada, ViiV
    Stock shareholder: None
    Other financial or material support: Advisory Committee: Abbvie, Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline, Merck Canada, ViiV

    DISCLAIMER

    The University of Nebraska Medical Center, Center for Continuing Education, College of Nursing Continuing Nursing Education, University of Florida College of Pharmacy, and Practice Point Communications present this information for educational purposes only. The content is provided solely by faculty who have been selected because of recognized expertise in their field. Participants have the professional responsibility to ensure that products are prescribed and used appropriately on the basis of their own clinical judgment and accepted standards of care. The University of Nebraska Medical Center, Center for Continuing Education, College of Nursing Continuing Nursing Education, the University of Florida College of Pharmacy, Practice Point Communications, and Gilead Sciences Medical Affairs assume no liability for the information herein. Accredited status as a continuing nursing education provider refers only to the University of Nebraska Medical Center College of Nursing Continuing Nursing Education continuing education activities, and does not imply UNMC or American Nurses Credentialing Center Commission on Accreditation endorsement of any commercial supporters.

    PRIVACY POLICY

    The University of Nebraska Medical Center, Center for Continuing Education, College of Nursing Continuing Nursing Education, the University of Florida College of Pharmacy, and Practice Point Communications protects the privacy of personal and other information regarding participants and educational collaborators. The University of Nebraska Medical Center, Center for Continuing Education, College of Nursing Continuing Nursing Education, University of Florida College of Pharmacy, and Practice Point Communications will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting purposes to the ACCME, ANCC, or ACPE.

    The University of Nebraska Medical Center, Center for Continuing Education, College of Nursing Continuing Nursing Education, the University of Florida College of Pharmacy, and Practice Point Communications maintain physical, electronic, and procedural safeguards that comply with federal regulations to protect against the loss, misuse or alteration of information that we have collected from you.

    COPYRIGHT INFORMATION

    Any unauthorized use of any materials on the site may violate copyright, trademark, and other laws. You may view, copy, and download information or software (“Materials”) found on the site subject to the following terms, conditions, and exceptions:

    The Materials are to be used solely for personal, noncommercial, informational and educational purposes. The materials are not to be modified. They are to be distributed in the format provided with the source clearly identified. The copyright information or other proprietary notices may not be removed, changed, or altered.

    Materials may not be published, uploaded, posted, transmitted (other than as set forth herin), without prior written permission.

    HARDWARE/SOFTWARE REQUIREMENTS

    Computer:
    • Hardware: A minimum of 512MB of RAM and a Pentium IV CPU for Intel-based hardware & PowerPC G4 or above for MAC.
    • Graphics/Monitor: A color monitor capable of a minimum of 1024 x 768 pixel resolution
    • Network: An Internet connection with 1Mbps available download & 256kbps bandwidth
    Software/Browser:
    • Windows XP or above running Internet Explorer 7 (service pack 2) or above.
    • MAC OSX 10.5 (Leopard) or above running Safari 5.1 or above, or any version of Chrome, Firefox or Opera published in the last two years.
    • A recent version of a Linux distribution or FreeBSD running Chrome v13, Opera 11.5, Firefox 5.0.1, or Epiphany 3.0.4 or above
    Mobile Device:
    • Any Apple iPad or iPad Mini running IOS 5 or above.
    • Most high-performance Android tablets such as the Kindle Fire or Samsung Galaxy S
    This presentation should be viewed with Microsoft PowerPoint. If Microsoft PowerPoint is not used to view the slides, data from charts may be incorrect or incomplete.

    COMMERCIAL SUPPORT ACKNOWLEDGMENT

    Supported by an independent educational grant from Gilead Sciences Medical Affairs


    20
    Supported by an independent educational grant from Gilead Sciences Medical Affairs
    November 30, 2017
    Mini Module
    6129


    Upcoming Live Activities


    • Women and HIV: Case Series
      The Boathouse at Rocketts Landing - Richmond, Virginia - Map
      Thursday, June 29, 2017 6:30 PM - Register

    • Clinical Controversies in HIV
      Russell's Steaks, Chops & More - Williamsville, New York - Map
      Monday, July 10, 2017 6:30 PM - Register

    • Lessons Learned: PrEP in Clinical Practice
      Ruth's Chris Steak House - San Diego, California - Map
      Wednesday, July 12, 2017 6:30 PM - Register

    • Living Longer, Living Better with HIV
      Ram's Head Inn - Galloway, New Jersey - Map
      Tuesday, July 18, 2017 6:30 PM - Register

    • Women and HIV: Case Series
      Ruth's Chris Steak House - Pikesville, Maryland - Map
      Wednesday, July 19, 2017 6:30 PM - Register

    • Adolescents and HIV: Guiding and Protecting the Vulnerable
      Ship Lantern Inn - Milton, New York - Map
      Thursday, July 20, 2017 6:00 PM - Register

    • Lessons Learned: PrEP in Clinical Practice
      Morton's The Steakhouse - Houston, Texas - Map
      Thursday, July 27, 2017 6:00 PM - Register

    • Essentials for Optimal HIV Care: Case Series
      Paramount Grill - Gainesville, Florida - Map
      Thursday, August 3, 2017 6:30 PM - Register

    • Lessons Learned: PrEP in Clinical Practice
      Sayaka Japanese Restaurant - Colton, California - Map
      Monday, August 7, 2017 6:30 PM - Register

    • Living Longer, Living Better with HIV
      Fleming's Prime Steakhouse - Palo Alto, California - Map
      Tuesday, August 8, 2017 6:30 PM - Register

    • Essentials for Optimal HIV Care: Case Series
      Bacco Ristorante - Southfield, Michigan - Map
      Wednesday, August 9, 2017 6:30 PM - Register

    • Essentials for Optimal HIV Care: Case Series
      Morton's The Steakhouse - Houston, Texas - Map
      Wednesday, August 23, 2017 6:30 PM - Register

    • Real-World Management of HIV/Hepatitis Coinfection
      Ruth's Chris Steak House - Nashville, Tennessee - Map
      Thursday, August 24, 2017 6:00 PM - Register

    • Post-Conference Update: 9th IAS Conference on HIV Science (IAS 2017) (Available August)
      Vivace - Raleigh, North Carolina - Map
      Tuesday, September 12, 2017 6:00 PM - Register

    • Post-Conference Update: 9th IAS Conference on HIV Science (IAS 2017) (Available August)
      MW Restaurant - Honolulu, Hawaii - Map
      Thursday, September 14, 2017 6:30 PM - Register

    • Post-Conference Update: 9th IAS Conference on HIV Science (IAS 2017) (Available August)
      Marks Prime - Gainesville, Florida - Map
      Thursday, October 5, 2017 6:30 PM - Register

    • Real-World Management of HIV/Hepatitis Coinfection
      Morton's The Steakhouse - Honolulu, Hawaii - Map
      Wednesday, October 18, 2017 6:30 PM - Register

    • Adolescents and HIV: Guiding and Protecting the Vulnerable
      Crowne Plaza - Baton Rouge, Louisiana - Map
      Friday, October 27, 2017 11:15 AM - Register

    • Transgender, Sex Workers and People Who Inject Drugs: Case Series
      Second Empire - Raleigh, North Carolina - Map
      Tuesday, December 5, 2017 6:00 PM - Register

    • Women and HIV: Case Series
      Mark's Prime Steakhouse - Gainesville, Florida - Map
      Thursday, December 7, 2017 6:30 PM - Register
    Copyright 2017 by Practice Point Communications